AEBi

Company Overview

Snapshot

Founded in June 2000 by Ilan Morad, PhD, AEBi operates with 1–10 employees. The company holds a patent and is currently in the Pre-Funding stage. In March 2019, the company garnered significant media attention regarding its cancer treatment research.

Business overview

Accelerated Evolution Biotechnologies (AEBi) is a development-stage biopharmaceutical company focused on the discovery and development of therapeutic peptides. The company utilizes an IP-protected combinatorial biology screening platform technology to identify binders to known targets and select functional molecules. AEBi's platform is designed to discover new lead compounds for disease targets, primarily serving the biopharmaceutical and pharmaceutical industries within the Health Tech & Life Sciences sector.

Strategic signal

In early 2019, AEBi attracted considerable media attention with claims of a potential cancer cure. While generating significant public interest, these claims also faced skepticism from various sources, highlighting the high-stakes and often controversial nature of breakthrough announcements in the biopharmaceutical sector. This event underscores the company's ambition in a critical medical field, but also points to the challenges of communicating early-stage research findings.

Company Intelligence Q&A

What is AEBi's primary focus?

AEBi is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic peptides for personalized cancer treatment.

When was AEBi founded?

AEBi was founded in June 2000.

What is AEBi's core technology?

AEBi has developed an IP-protected combinatorial biology screening platform technology designed to find binders to known targets and select functional molecules for disease targets.

Has AEBi received media attention for its research?

Yes, in March 2019, AEBi's cancer treatment research was featured in an article by The Irish Times, discussing its potential significance. In January 2019, The Times of Israel and Forbes also reported on the company's claims regarding a cancer cure.

Where is AEBi incorporated?

AEBi was incorporated at the Weizmann Institute's ITEK technological incubator in Ness Ziona, Israel.